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Abstract
BACKGROUND
Polycystic liver disease (PCLD) with a large cystic volume deteriorates the
quality of life of patients through substantial effects on the adjacent organs,
recurrent cyst infections, cyst rupture, and hemorrhage. Surgical or radiological
intervention is usually needed to alleviate these symptoms. We report a rare case
of the cystic metastasis of renal cell carcinoma (RCC), which was misdiagnosed as
PCLD, as a result of the clinical and radiological similarity between these
disorders.
CASE SUMMARY
A 74-year-old female who had undergone nephrectomy for papillary-type RCC
(PRCC) was suffering from abdominal pain and the recurrent intracystic
hemorrhage of multiple cysts in the liver. Imaging studies and aspiration
cytology of the cysts showed no evidence of malignancy. With a diagnosis of
autosomal dominant polycystic liver disease, the patient received hepatectomy
for the purpose of mass reduction and infectious cyst removal. Surgery was
performed without complications, and the patient was discharged on
postoperative day 14. Postoperatively, the pathology revealed a diagnosis of
recurrent PRCC with cystic formation.
CONCLUSION
This case demonstrates the importance of excluding the cystic metastasis of a
cancer when liver cysts are observed.
Key words: Polycystic liver disease; Polycystic kidney disease; Cystic metastasis; Renal
cell carcinoma; Case report
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Core tip: Polycystic liver disease (PCLD) usually exhibits typical presentations in
imaging studies, but the diagnosis is sometimes challenging because of the late onset of
this genetic disorder and the atypical presentations of other diseases. In a case of cystic
metastasis of renal cell carcinoma, the disease could be misdiagnosed as PCLD due to
the clinical and radiological similarity between these disorders. This case demonstrates
that when multiple cystic lesions are observed in the liver, it is important to first exclude
the cystic metastasis of a cancer. Additionally, some specific types of cancer can have
different presentations at metastasis and recurrence.
Citation: Liang C, Takahashi K, Kurata M, Sakashita S, Oda T, Ohkohchi N. Recurrent renal
cell carcinoma leading to a misdiagnosis of polycystic liver disease: A case report. World J
Gastroenterol 2019; 25(18): 2264-2270
URL: https://www.wjgnet.com/1007-9327/full/v25/i18/2264.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i18.2264
INTRODUCTION
Polycystic liver disease (PCLD) is defined as the presence of more than 20 cysts in the
liver or the presence of more than 4 cysts in the liver with a family history of the
disease. PCLD is a relatively rare disease, which is estimated to be present in 0.05%-
0.53%  of  the  total  population[1].  PCLD  manifests  as  clinical  symptoms  such  as
tiredness, fullness, shortness of breath, dissatisfaction with the abdomen size, limited
mobility and early satiety, which significantly deteriorate the patient’s quality of life[2].
PCLD  is  classified  as  one  of  two  inherited  disorders,  i.e.,  autosomal  dominant
polycystic kidney disease (ADPKD) and autosomal dominant polycystic liver disease
(ADPLD).  ADPLD  is  distinguished  from  ADPKD  by  the  absence  of  polycystic
kidneys. The mutations present in polycystic kidney disease (PKD1 and PKD2) are
causative genes for ADPKD, while 20% of ADPLD is caused by mutations in the
protein kinase C substrate 80K-H (PRKCSH) or SEC63, leaving the other 80% with
unknown etiologies. PCLD, together with congenital hepatic fibrosis, is a type of
disease that is  characterized by the dysfunction of the primary cilium[3].  Current
radiological and surgical interventions for “symptomatic” PCLD patients include
aspiration-sclerotherapy,  fenestration,  hepatectomy  and  liver  transplantation.
Hepatectomy is usually indicated for Gigot type II PCLD, in which one liver segment
is retained with unaffected liver parenchyma[4].
The diagnosis of PCLD is sometimes challenging. Typical differential diagnoses
include ciliated hepatic foregut cysts, hepatobiliary cystadenomas, and parasitic cysts.
However, in very rare cases, the cystic metastasis of a cancer becomes an important
differential diagnosis that significantly changes the treatment strategy. The origins of
cystic metastasis include colon, pancreas, ovary, kidney, neuroendocrine, and prostate
cancer[1]. Here, we describe a rare case of the cystic metastasis of renal cell carcinoma
(RCC), for which hepatectomy was performed due to the misdiagnosis of ADPLD.
CASE PRESENTATION
Chief complaints
A 74-year-old female complained of right upper quadrant abdominal pain when she
presented at our hospital. Computed tomography (CT) with intravenous contrast
demonstrated the local recurrence of RCC in the ipsilateral lymph nodes and multiple
liver cysts.
History of present illness
The patient was diagnosed with left renal cancer and liver cysts in the bilateral lobes 4
years  prior  (Figure  1A).  There  was  one  large  cyst  and  several  small  cysts,  as
demonstrated by a CT scan. The liver cysts appeared as well-demarcated and water-
dense sacs without mural nodules. The patient had not received health screening for
20 years. Left nephrectomy with ipsilateral adrenalectomy was performed. Pathology
revealed PRCC, G2, INF-α, pT2a, N0, M0, and v (-) (Figure 1B). No cysts were found
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in the excision. Eight months prior to the surgery, the patient complained of right
upper quadrant pain secondary to recurrent intracystic hemorrhage and received cyst
aspiration and sclerotherapy. Aspiration cytology showed no evidence of malignancy,
and the pain recurred soon after the treatment.
History of past illness
The patient had a medical history of hypertension and hyperlipemia.
Family history
The patient did not have a family history of PCLD.
Physical examination
The patient’s temperature was 36.2 °C, heart rate was 82 bpm, respiratory rate was 14
breaths per minute, blood pressure was 140/99 mmHg and oxygen saturation in room
air was 98%. A surgical scar was located in the left upper abdomen. In the abdominal
examination,  an abdominal  mass  was observed in  the  umbilical  region,  shifting
dullness was present and liver cysts were palpable.
Laboratory examinations
Blood analysis revealed anemia with a hemoglobin level of 7.8 g/dL, white blood cells
at 2.3 × 109/L, with a normal hematocrit and platelet count. The prothrombin, partial
thromboplastin times and d-dimers were normal. The serum albumin was low, at 3.2
mg/dL. In the blood biochemistry analysis, the lactate dehydrogenase was high, at
262  U/L,  with  a  high alkaline  phosphatase  level,  at  626  U/L,  and a  γ-glutamyl
transpeptidase  rate  of  101  U/L.  The  alanine  aminotransferase  and  aspartate
aminotransferase  were  normal.  The  urine  analysis  was  normal.  The
electrocardiogram, chest X-ray and arterial blood gas were also normal.
Imaging examinations
CT  with  intravenous  contrast  demonstrated  the  local  recurrence  of  RCC  in  the
ipsilateral lymph nodes and multiple liver cysts, which had increased in size and
number (Figure 2A and B). The cysts were various in sizes, but the borders were clear,
and there was no sign of enhancement in the cystic walls.
FINAL DIAGNOSIS
Considering the fact that multiple cysts existed, mainly in the right lobe, while normal
liver areas were retained in the lateral section, the patient was classified as having
Type II PCLD, based on Gigot's classification (Figure 2B and C).
TREATMENT
Tumor  resection  with  lymphadenectomy  was  planned  to  ensure  the  complete
resection of  the locally  recurrent  RCC. Further,  with a  diagnosis  of  PCLD, right
lobectomy combined with cyst fenestration was planned to provide an optimized
method for alleviating the symptoms.
OUTCOME AND FOLLOW-UP
The  surgery  was  completed  without  major  intraoperative  complications.  In  the
pathological  report  of  the liver  specimens,  cells  located focally around the cysts
formed tubule-papillary structures that were mostly lined with single-cuboidal or
low-columnar epithelial cells with scant cytoplasm and uniform nuclei, which were
morphologically  similar  to  PRCC  by  hematoxylin-eosin  staining  (Figure  3A)[5].
Immunohistochemical staining showed the presence of CD10+ cells in the edges of the
cysts (Figure 3B), while CK7+ and CK19+ cells were absent (Figure 3B-D). Combined
with the results of H&E staining, the diagnosis of PRCC liver metastasis was verified.
The patient was discharged on postoperative day 14 and started sunitinib treatment 1
mo after the hepatectomy. It has been 2 years since the surgery was performed. The
pain was relived after the surgery, and the patient is still alive. However, lymph node
metastases and lung metastases appeared after a few months, and the cysts occupying
the remnant liver are growing, causing recurrent abdominal pain. The patient is now
managed with symptomatic treatment.
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Figure 1
Figure 1  Abdominal computed tomography of the liver and pathologic findings from the primary tumor. Abdominal computed tomography demonstrated left
renal cancer (arrow) and bilateral liver cysts. A: There was one large cyst and several small cysts. The borders of the liver cysts were clear, with no mural nodules. B:
Pathology of the primary tumor revealed papillary renal cell carcinoma, G2, INF-α, T2a, N0, M0, v (-), × 20.
DISCUSSION
PRCC is the second most frequent RCC subtype, followed by clear cell-type RCC
(CRCC). PRCC is known to metastasize less frequently than CRCC, with a reported
incidence of 5.7%-11%[6]. The lung and bone are common sites of metastases, whereas
the metastasis of the liver is less frequent (16.1%)[6,7]. PRCC can be classified as having
solid or cystic masses. Cystic-type PRCC may be a result of its inherent architecture or
of cystic degeneration[6].  Cystic metastasis of RCC is very rare[7].  Some cases with
cystic lymph node metastases or dissemination have been previously reported in the
literature[8-11].
Liver  cysts  can  be  classified  as  developmental,  neoplastic,  inflammatory,  or
miscellaneous[12]. The differential diagnosis of liver cysts is sometimes challenging,
and excluding metastasis is one of the highest priorities. In typical cases of cystic
metastatic cancers, the borders of the cystic lesions are typically heterogeneous and
ill-defined[13]. The cystic walls are irregular, and the vessels are amputated; however,
these characteristics are not observed in cases of PCLD. Cystic metastases usually
have a peripheral enhancing rim on the arterial phase of a CT scan and magnetic
resonance imaging, while PCLD usually does not have this feature[14]. Peribiliary cysts,
which are also seen with high incidence, are usually located at the hilum and adjacent
to the hepatic ducts, and the cyst sizes are smaller than 10 mm[13,14]. The misdiagnosis
of  cystic  liver  disease  can  be  critical  since  the  treatment  strategy  is  completely
different.
We described a rare case of the cystic metastasis of PRCC, which was misdiagnosed
as PCLD. This case is important in that it demonstrates that PRCC can manifest with
different presentations at metastasis and recurrence, i.e.,  multiple cyst formation,
imitating PCLD[7,13]. In our case, the preoperative images of the liver cysts indicated
that there were clear borders with no signs of enhancement in the cystic walls, which
were characteristically similar to the cysts of PCLD, and the aspiration cytology was
negative for cancer cells. Pathologically, the cystic walls were irregular, and the cells
around the cysts were morphologically compatible with RCC. The diagnosis of RCC
was  confirmed  by  the  presence  of  CD10+  cells  around  the  cysts,  which  is  a
characteristic surface marker of RCC. It was quite unlikely that cystic liver metastasis
occurred to a liver affected by PCLD, since all  the cysts that were pathologically
investigated showed the malignant characteristics described above. Since CA 50 was
reported as a potential tumor marker for cystic RCC[15], we could have tested the CA
50 in the blood and the cystic fluid from repeated fine-needle aspiration. Further, 18F-
fluorodeoxyglucose (FDG) positron emission tomography/CT (PET/CT) is highly
sensitive and accurate, with a sensitivity of 97% and a specificity of 75% for hepatic
metastasis[10]. It has been reported to show intense uptake in cystic liver metastasis
compared with  that  in  benign cysts[16].  We could have  checked PET/CT scan to
confirm the malignancy of the cysts if we had taken metastasis into consideration.
The treatment for metastatic renal cancer is debated, and the therapeutic options
are limited. The National Health Service of England Guidelines stated that sunitinib
and pazopanib are  first-line  systemic  therapies  for  metastatic  RCC[17].  Complete
resection is the only choice for patients with metastatic RCC to have a satisfactory
prognosis, with 5-year overall survival rates of 15 to 60%[18]. However, patients with
bilateral  multiple  metastatic  RCC,  such  as  our  patient,  are  not  candidates  for
hepatectomy because radical resection cannot be performed, and the surgery will not
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Figure 2
Figure 2  Images from abdominal computed tomography. Local recurrence of renal cell carcinoma was detected in the ipsilateral lymph nodes and in the left
lumbar vertebra (B, white arrow). There was a diffuse involvement of the liver parenchyma, with multiple cysts and large areas of noncystic liver parenchyma
remaining (C); A: coronal view; B and C: transverse view.
prolong the overall survival time of the patients[19,20]. In our case, since the patient
suffered  from  acute  abdominal  pain  and  recurrent  intracystic  hemorrhage,  we
performed hepatectomy following the diagnosis of PCLD. However, as the cysts were
located diffusely in the bilateral lobe, the patient would have had no indication for
hepatectomy if  she had been correctly diagnosed with PRCC preoperatively.  We
should  have  started  with  chemotherapy  and  palliative  care,  using  opioids  and
additional adjuvants to alleviate the abdominal symptoms[21]. This case reminds us of
the following: first, when multiple cystic lesions are observed throughout the liver
parenchyma in patients with cancer, it is important to first exclude metastasis; and
second, some specific types of cancer can show different presentations at metastasis
and recurrence, which could cause preoperative misdiagnosis.
CONCLUSION
In a patient with cystic neoplasms of the liver, the diagnosis remains challenging in
everyday practice. Cystic lesions may present as solitary or multiple cysts and may
range from benign to malignant. To the best of our knowledge, this is the first report
of cystic liver metastasis from PRCC. The most important implication of this case is
that PCLD must be distinguished from the cystic metastasis of a cancer, which can
contribute  to  a  profoundly  better  prognosis  as  a  result  of  the  use  of  an  optimal
treatment approach.
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Figure 3
Figure 3  Pathological findings from the metastatic liver cysts. A: Cells around the cysts showed a basophilic morphologic appearance with low-grade nuclear
features that were morphologically consistent with papillary-type renal cell carcinoma cells, × 20. B-D: Immunohistochemical staining showed the occasional presence
of CD10+ cells in the edges of the cysts, while CK7+ and CK19+ cells were not observed, × 20.
REFERENCES
1 Chen KW, Chen HW, Ou TM, Tsai WC, Hsieh TY. Hepatic cystic metastatic tumors from a locally
controlled nasopharyngeal carcinoma. Advances in Digestive Medicine 2016; 3: 69-72 [DOI:
10.1016/j.aidm.2014.09.001]
2 Neijenhuis MK, Kievit W, Verheesen SM, D'Agnolo HM, Gevers TJ, Drenth JP. Impact of liver volume
on polycystic liver disease-related symptoms and quality of life. United European Gastroenterol J 2018; 6:
81-88 [PMID: 29435317 DOI: 10.1177/2050640617705577]
3 Wills ES, Roepman R, Drenth JP. Polycystic liver disease: ductal plate malformation and the primary
cilium. Trends Mol Med 2014; 20: 261-270 [PMID: 24506938 DOI: 10.1016/j.molmed.2014.01.003]
4 Gevers TJ, Drenth JP. Diagnosis and management of polycystic liver disease. Nat Rev Gastroenterol
Hepatol 2013; 10: 101-108 [PMID: 23296249 DOI: 10.1038/nrgastro.2012.254]
5 Peckova K, Martinek P, Pivovarcikova K, Vanecek T, Alaghehbandan R, Prochazkova K, Montiel DP,
Hora M, Skenderi F, Ulamec M, Rotterova P, Daum O, Ferda J, Davidson W, Ondic O, Dubova M, Michal
M, Hes O. Cystic and necrotic papillary renal cell carcinoma: prognosis, morphology,
immunohistochemical, and molecular-genetic profile of 10 cases. Ann Diagn Pathol 2017; 26: 23-30
[PMID: 28038707 DOI: 10.1016/j.anndiagpath.2016.10.007]
6 Vikram R, Ng CS, Tamboli P, Tannir NM, Jonasch E, Matin SF, Wood CG, Sandler CM. Papillary renal
cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics 2009; 29: 741-
754; discussion 755-757 [PMID: 19448113 DOI: 10.1148/rg.293085190]
7 Psutka SP, Master VA. Role of metastasis-directed treatment in kidney cancer. Cancer 2018; 124: 3641-
3655 [PMID: 29689599 DOI: 10.1002/cncr.31341]
8 Dwivedi AND, Mourya C. Disseminated cystic nodal metastasis in renal cell carcinoma mimicking
systemic hydatidosis on imaging. J Cancer Res Ther 2018; 14: 441-443 [PMID: 29516935 DOI:
10.4103/0973-1482.174526]
9 Ishii N, Yonese J, Tsukamoto T, Maezawa T, Ishikawa Y, Fukui I. Retroperitoneal cystic metastasis from
a small clear cell renal carcinoma. Int J Urol 2001; 8: 637-639 [PMID: 11903692 DOI:
10.1046/j.1442-2042.2001.00385.x]
10 Rastogi R. Retroperitoneal cystic metastases from renal cell carcinoma. Saudi J Kidney Dis Transpl 2008;
19: 244-246 [PMID: 18310876]
11 Yamashita T, Morozumi M, Higashi M, Momose S, Tamaru JI. Retroperitoneal Cystic Nodal Metastasis
of Renal Cell Carcinoma. Case Rep Urol 2018; 2018: 1605102 [PMID: 29854548 DOI:
10.1155/2018/1605102]
12 Mortelé KJ, Ros PR. Cystic focal liver lesions in the adult: differential CT and MR imaging features.
Radiographics 2001; 21: 895-910 [PMID: 11452064 DOI: 10.1148/radiographics.21.4.g01jl16895]
13 Del Poggio P, Buonocore M. Cystic tumors of the liver: a practical approach. World J Gastroenterol 2008;
14: 3616-3620 [PMID: 18595127 DOI: 10.3748/wjg.14.3616]
14 Borhani AA, Wiant A, Heller MT. Cystic hepatic lesions: a review and an algorithmic approach. AJR Am
J Roentgenol 2014; 203: 1192-1204 [PMID: 25415696 DOI: 10.2214/AJR.13.12386]
15 Ljungberg B, Holmberg G, Sjödin JG, Hietala SO, Stenling R. Renal cell carcinoma in a renal cyst: a case
report and review of the literature. J Urol 1990; 143: 797-799 [PMID: 2179585]
16 Radhakrishnan V, Thulkar S, Karunanithi S, Tanveer N, Bakhshi S. Nasopharyngeal carcinoma with
splenic and cystic liver metastases in a pediatric patient: 18F-FDG PET-CT findings. Pediatr Radiol 2010;
40 Suppl 1: S79-S82 [PMID: 20922367 DOI: 10.1007/s00247-010-1844-y]
17 National Health Service of England.   Guidelines for the management of renal cancer. Available from:
WJG https://www.wjgnet.com May 14, 2019 Volume 25 Issue 18
Liang C et al. RCC PCLD
2269
https://www.england.nhs.uk/mids-east/wp-content/uploads/sites/7/2018/05/guidelines-for-the-
management-of-renal-cancer.pdf
18 Krabbe LM, Bagrodia A, Margulis V, Wood CG. Surgical management of renal cell carcinoma. Semin
Intervent Radiol 2014; 31: 27-32 [PMID: 24596437 DOI: 10.1055/s-0033-1363840]
19 Grimes NG, Devlin JM, Dunne DF, Jones RP, Poston GJ, Fenwick SW, Malik HZ. A systematic review
of the role of hepatectomy in the management of metastatic renal cell carcinoma. Eur J Surg Oncol 2014;
40: 1622-1628 [PMID: 25228053 DOI: 10.1016/j.ejso.2014.08.472]
20 Bakoyiannis A, Delis S, Triantopoulou C, Dervenis C. Rare cystic liver lesions: a diagnostic and
managing challenge. World J Gastroenterol 2013; 19: 7603-7619 [PMID: 24282350 DOI:
10.3748/wjg.v19.i43.7603]
21 Are M, McIntyre A, Reddy S. Global disparities in cancer pain management and palliative care. J Surg
Oncol 2017; 115: 637-641 [PMID: 28230243 DOI: 10.1002/jso.24585]
WJG https://www.wjgnet.com May 14, 2019 Volume 25 Issue 18
Liang C et al. RCC PCLD
2270
Published By Baishideng Publishing Group Inc
7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Telephone: +1-925-2238242
Fax: +1-925-2238243
E-mail: bpgoffice@wjgnet.com
Help Desk:http://www.f6publishing.com/helpdesk
http://www.wjgnet.com
© 2019 Baishideng Publishing Group Inc. All rights reserved.
